Zymeworks Inc. (ZYME)
NASDAQ·Healthcare·Biotechnology
$28.12
-1.56%
Mkt Cap $2.10B
Analyst Ratings
Buy
8
Hold
2
Sell
0
Price Target (16 analysts)
$34.67
Range $26.00 – $40.00
Implied Upside
+23.3%
Consensus $34.67 vs current $28.12
NASDAQ·Healthcare·Biotechnology
$28.12
-1.56%
Mkt Cap $2.10B
Buy
8
Hold
2
Sell
0
Price Target (16 analysts)
$34.67
Range $26.00 – $40.00
+23.3%
Consensus $34.67 vs current $28.12